Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to JUUL ENDS
NCT04107779 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 279
Last updated 2020-07-28
Summary
A Randomized, Open Label, Parallel Group Study in Adult Smokers to Evaluate Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to using JUUL Electronic Nicotine Delivery Systems With Two Different Nicotine Concentrations
Conditions
- Electronic Cigarette Use
- Cigarette Use, Electronic
- Tobacco Use
- Tobacco Smoking
Interventions
- OTHER
-
Switch from UB of Combustible Cigarette to JUUL 5% Virginia Tobacco ENDS
JUUL 5%, ENDS for 6-days in confinement
- OTHER
-
Switch from UB of Combustible Cigarette to JUUL 3% Virginia Tobacco ENDS
JUUL 3%, ENDS for 6-days in confinement
- OTHER
-
Switch from UB of Combustible Cigarette to JUUL 5% Mint ENDS
JUUL 5%, ENDS for 6-days in confinement
- OTHER
-
Switch from UB of Combustible Cigarette to JUUL 3% Mint ENDS
JUUL 3%, ENDS for 6-days in confinement
- OTHER
-
Switch from UB of Combustible Cigarette to JUUL 5% Menthol ENDS
JUUL 5%, ENDS for 6-days in confinement
- OTHER
-
Switch from UB of Combustible Cigarette to JUUL 3% Menthol ENDS
JUUL 3%, ENDS for 6-days in confinement
- OTHER
-
Switch from UB of Combustible Cigarette to JUUL 5% Mango ENDS
JUUL 5%, ENDS for 6-days in confinement
- OTHER
-
Switch from UB of Combustible Cigarette to JUUL 3% Mango ENDS
JUUL 3%, ENDS for 6-days in confinement
- OTHER
-
Switch to Dual-use of JUUL 5% and UB of Combustible Cigarette
Combination use of JUUL 5% (Virginia Tobacco, Mint, Menthol or Mango flavored) and usual brand combustible cigarettes for 6-days in confinement
- OTHER
-
Tobacco/Nicotine Abstention
No smoking for 6-days in confinement.
- OTHER
-
Usual Brand of cigarettes
Continue smoking UB for 6-days in confinement.
Sponsors & Collaborators
-
Juul Labs, Inc.
lead INDUSTRY
Principal Investigators
-
Mark Rubinstein, MD · Juul Labs, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-09-17
- Primary Completion
- 2020-02-17
- Completion
- 2020-06-24
Countries
- United States
Study Locations
More Related Trials
-
Characterize the Nicotine Uptake and Subjective Effects With Use of JUUL Electronic Nicotine Delivery Systems
NCT04123041 ·Status: COMPLETED ·Phase: NA
-
Assess Biomarkers of Tobacco Exposure and Nicotine Pharmacokinetics in Smokers After a 5-Day In-Clinic Confinement Switch to an Electronic Cigarette or Nicotine Gum
NCT02323438 ·Status: COMPLETED ·Phase: NA
-
Clinical Study Comparing 7 ENDS Products and 1 Combustible Cigarette Using 2 Delivery Methods.
NCT03700112 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
NCT05658471 ·Status: COMPLETED ·Phase: NA
-
A Study to Characterize Puff Topography With Use of JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers
NCT03596034 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Changes in Smokers Using An Oral Tobacco-Derived Nicotine Product
NCT04079933 ·Status: COMPLETED ·Phase: NA
-
Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence
NCT05487456 ·Status: COMPLETED ·Phase: NA
-
Effects of E-Cigarettes in Menthol Smokers
NCT05949034 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Changes in Smokers Using Oral Tobacco-derived Nicotine Products.
NCT03692078 ·Status: COMPLETED ·Phase: NA
-
Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users
NCT03710590 ·Status: COMPLETED ·Phase: NA
-
Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users
NCT04003805 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
CSD231005 Nicotine Pouch Biomarkers of Exposure
NCT06303115 ·Status: COMPLETED ·Phase: NA
-
Characterization of Nicotine Exposure and Urge-to-Smoke Following Use of Electronic and Conventional Cigarettes
NCT02210754 ·Status: COMPLETED ·Phase: NA
-
Single-dose Pharmacokinetics of Oral Nicotine Replacement Products
NCT01228617 ·Status: COMPLETED ·Phase: NA
-
Effects of an Oral Nicotine Product in Smokeless Tobacco Users
NCT05280769 ·Status: COMPLETED ·Phase: NA
-
Characterization of Product Use in Smokers Switching From Cigarettes to a RELX Electronic Nicotine Delivery System
NCT04708106 ·Status: COMPLETED ·Phase: NA
-
Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With Use of RELX ENDS Products by ENDS Consumers
NCT04620616 ·Status: COMPLETED ·Phase: NA
-
Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes
NCT05383508 ·Status: COMPLETED ·Phase: NA
-
Use Behavior, Nicotine Uptake, and Subjective Effects Comparison of Tobacco and Menthol e-Liquids by ENDS Consumers
NCT05134415 ·Status: COMPLETED ·Phase: NA
-
CSD170501: Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette
NCT03170674 ·Status: COMPLETED ·Phase: NA
-
E-cigarettes and Blood Vessel Function
NCT02740595 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
NCT04231539 ·Status: COMPLETED ·Phase: NA
-
Comparison of Nicotine Plasma Concentrations and Subjective Effects for Three Menthol Electronic Cigarettes vs Combustible Menthol Cigarettes and Nicotine Gum
NCT02664012 ·Status: COMPLETED ·Phase: NA
-
Assessing the Effect of Flavor on ENDS Users' Experiences and Exposures
NCT04192032 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Changes in Smokers Using on!® Nicotine Pouches
NCT05664672 ·Status: COMPLETED ·Phase: NA